<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-title>BMC Infectious Diseases</journal-title><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2334-6-82</article-id><article-id pub-id-type="pmid">16672072</article-id><article-id pub-id-type="doi">10.1186/1471-2334-6-82</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname> Chong</surname><given-names>Wai Po</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>h9820905@graduate.hku.hk</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Ip</surname><given-names>WK Eddie</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>WIP@partners.org</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Tso</surname><given-names>Gloria Hoi Wan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>h98083405@hkusua.hku.hk</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Ng</surname><given-names>Man Wai</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ivy_natsu@yahoo.com.hk</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Wong</surname><given-names>Wilfred Hing Sang</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>whswong@hkucc.hku.hk</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Law</surname><given-names>Helen Ka Wai</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hkwlaw@hkucc.hku.hk</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Yung</surname><given-names>Raymond WH</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>rwhyung@ha.org.hk</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Chow</surname><given-names>Eudora Y</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>chowe@ha.org.hk</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Au</surname><given-names>KL</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>klau@ha.org.hk</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Chan</surname><given-names>Eric YT</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>eytchan@ha.org.hk</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Lim</surname><given-names>Wilina</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>wllim@pacific.net.hk</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Peiris</surname><given-names>JS Malik</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>malik@hkucc.hku.hk</email></contrib><contrib id="A13" corresp="yes" contrib-type="author"><name><surname>Lau</surname><given-names>Yu Lung</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lauylung@hkucc.hku.hk</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Paediatrics and Adolescent Medicine, The Hong Kong Jockey Club Research Centre, The University of Hong Kong, Pokfulam, Hong Kong SAR, China</aff><aff id="I2"><label>2</label>Department of Pathology, Pamela Nethersole Youde Hospital, Hong Kong SAR, China</aff><aff id="I3"><label>3</label>Department of Pathology, United Christian Hospital, Hong Kong SAR, China</aff><aff id="I4"><label>4</label>Princess Margaret Hospital, Hong Kong SAR, China</aff><aff id="I5"><label>5</label>Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China</aff><aff id="I6"><label>6</label>Government Virus Unit, Department of Health, Hong Kong SAR, China</aff><aff id="I7"><label>7</label>Department of Microbiology, The Hong Kong Jockey Club Research Centre, Pokfulam, The University of Hong Kong, Hong Kong SAR, China</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>4</day><month>5</month><year>2006</year></pub-date><volume>6</volume><fpage>82</fpage><lpage>82</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/6/82"/><history><date date-type="received"><day>7</day><month>2</month><year>2006</year></date><date date-type="accepted"><day>4</day><month>5</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Po Chong et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Po Chong et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Chong Wai Po h9820905@graduate.hku.hk </dc:author><dc:title> The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Infectious Diseases 6(1): 82-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2334(2006)6:1&#x0003c;82&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2334</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Cytokines play important roles in antiviral action. We examined whether polymorphisms of <italic>IFN-&#x003b3;</italic>,<italic>TNF-&#x003b1; </italic>and <italic>IL-10 </italic>affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS).</p></sec><sec sec-type="methods"><title>Methods</title><p>A case-control study was carried out in 476 Chinese SARS patients and 449 healthy controls. We tested the polymorphisms of <italic>IFN-&#x003b3;</italic>,<italic>TNF-&#x003b1; </italic>and <italic>IL-10 </italic>for their associations with SARS.</p></sec><sec><title>Results</title><p><italic>IFN-&#x003b3; </italic>+874A allele was associated with susceptibility to SARS in a dose-dependent manner (<italic>P </italic>&#x0003c; 0.001). Individuals with <italic>IFN-&#x003b3; </italic>+874 AA and AT genotype had a 5.19-fold (95% Confidence Interval [CI], 2.78-9.68) and 2.57-fold (95% CI, 1.35-4.88) increased risk of developing SARS respectively. The polymorphisms of <italic>IL-10 </italic>and <italic>TNF-&#x003b1; </italic>were not associated with SARS susceptibility.</p></sec><sec><title>Conclusion</title><p><italic>IFN-&#x003b3; </italic>+874A allele was shown to be a risk factor in SARS susceptibility.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Severe acute respiratory syndrome (SARS) is an infectious disease caused by SARS coronavirus [<xref ref-type="bibr" rid="B1">1</xref>] with &#x0003e;8000 cases and 774 deaths reported in 2003 [<xref ref-type="bibr" rid="B2">2</xref>]. Much progress has been made in understanding SARS coronavirus but the pathogenesis is still unclear [<xref ref-type="bibr" rid="B3">3</xref>]. It was reported that old age, diabetes mellitus and heart disease were risk factors for adverse prognosis of SARS [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>], however, little is known about the contribution of genetic factors. We have demonstrated that genetic haplotypes associated with low serum mannose-binding lectin (MBL) were associated with SARS [<xref ref-type="bibr" rid="B7">7</xref>] and our findings were recently replicated [<xref ref-type="bibr" rid="B8">8</xref>]. Recently, homozygotes for <italic>CLEC4M </italic>tandem repeats were reported to be less susceptible to SARS in Hong Kong Chinese [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Cytokines are known to be important in antiviral action. Interferon (IFN)-&#x003b3; from T and natural killer (NK) cells is important in driving the T helper cell type 1 (Th1) responses. It also activates monocytes and macrophages, which in turn take part in antiviral responses by producing free radicals and pro-inflammatory cytokines like tumor necrosis factor (TNF)-&#x003b1;. [<xref ref-type="bibr" rid="B10">10</xref>]. TNF-&#x003b1; then regulates expression of neutrophil-endothelial cell adhesion molecules and chemokines, which recruit leukocytes to the site of infection [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Thus, IFN-&#x003b3;and TNF-&#x003b1; play important role in antiviral response and inflammation.</p><p>Interleukin 10 (IL-10) is an antiinflammatory cytokine that inhibits the activation and effector function of Th1 cells, monocytes, and macrophages [<xref ref-type="bibr" rid="B14">14</xref>]. IL-10 appears to limit and ultimately terminate inflammatory responses by blocking the expression of a number of pro-inflammatory cytokines and chemokines [<xref ref-type="bibr" rid="B15">15</xref>]. In animal model, IL10 counteracts the inflammatory response by inhibiting TNF-&#x003b1; production and neutrophil activation, and leads to a reduction of the lung tissue injury [<xref ref-type="bibr" rid="B16">16</xref>]. Thus, IL-10 plays an important role in regulating many immune and inflammatory processes. Various studies showed that a high IL-10 level would result in suppression of innate host defense and lead to increasing susceptibility of the host to various microbes and death [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>].</p><p>In this study, we hypothesized that the polymorphisms of the cytokine genes, i.e. <italic>IFN-&#x003b3; </italic>+874A/T, <italic>TNF-&#x003b1; </italic>-308G/A, <italic>IL-10 </italic>-1082G/A and -592A/C, might be associated with SARS. These genes were chosen based on their functions in antiviral response and inflammation regulation that may be involved in SARS pathogenesis and their polymorphisms based on their potential regulation on gene expression (Table <xref ref-type="table" rid="T1">1</xref>). We tested our hypotheses in 476 SARS patients and 449 healthy controls and found that polymorphism of <italic>IFN-&#x003b3; </italic>+874A allele was associated with susceptibility to SARS in a dose-dependent manner.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Polymorphisms of the genes genotyped</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Genes</td><td align="left">SNPs</td><td align="left">rs number</td><td align="left">References</td></tr></thead><tbody><tr><td align="left"><italic>IFN-&#x003b3;</italic></td><td align="left"><italic>IFN-&#x003b3; </italic>+874 A/T</td><td align="left">rs2430561</td><td align="left">[23]</td></tr><tr><td align="left"><italic>IL-10</italic></td><td align="left"><italic>IL-10 </italic>-1082 A/G</td><td align="left">rs1800896</td><td align="left">[23,26-27]</td></tr><tr><td></td><td align="left"><italic>IL-10 </italic>-592 A/C</td><td align="left">rs1800872</td><td></td></tr><tr><td align="left"><italic>TNF-&#x003b1;</italic></td><td align="left"><italic>TNF-&#x003b1; </italic>-308G/A</td><td align="left">rs1800629</td><td align="left">[28]</td></tr></tbody></table></table-wrap></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patient populations</title><p>The study was approved by the Clinical Research Ethics Committee of the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster and included 476 Chinese patients with SARS (201 male, mean age = 39.8 &#x000b1; 15.2) and 449 ethnically matched healthy controls from Red Cross (273 male, mean age = 29.1 &#x000b1; 10.4). At least 95% of the patients were documented with SARS-CoV antibody seroconversion and/or detectable SARS-CoV RNA in respiratory secretions by RT-PCR.</p></sec><sec><title>Genotyping</title><p><italic>IFN-&#x003b3; </italic>+874A/T, <italic>IL-10 </italic>-1082G/A and -592A/C were genotyped by TaqMan system (Applied Biosystems, Foster City, CA, USA) as described previously [<xref ref-type="bibr" rid="B20">20</xref>]. <italic>TNF-&#x003b1; </italic>-308 G/A was also genotyped by TaqMan system with same condition. The sequences of the primers were 5'-CCT GGT CCC CAA AAG AAA TG-3' and 5'-TCT TCT GGG CCA CTG ACT GA-3' and the probes were 6-FAM-TTG AGG GGC ATG <bold>G</bold>GG ACG G-TAMRA and VIC-TTG AGG GGC ATG <bold>A</bold>GG ACG GG-TAMRA.</p></sec><sec><title>Statistical analysis</title><p>The frequencies of genotypes and alleles of the 4 single nucleotide polymorphisms (SNPs) were compared between the SARS patients and healthy controls by 3 &#x000d7; 2 and 2 &#x000d7; 2 chi square test respectively. In case of significance, logistic regression was used for calculating OR with 95% CI and corresponding <italic>P-</italic>values between groups by controlling age and sex as covariables. The genotypes of all SNPs were tested for Hardy-Weinberg equilibrium (HWE) by chi square test.</p></sec></sec><sec><title>Results and discussion</title><p>Our case-control study genotyped the 4 SNPs <italic>IFN-&#x003b3; </italic>+874A/T, <italic>TNF-&#x003b1; </italic>-308G/A, <italic>IL-10 </italic>-1082G/A and -592A/C in 476 Chinese patients with SARS and 449 healthy controls. The genotype distributions and allele frequencies of these 4 SNPs were shown in Table <xref ref-type="table" rid="T2">2</xref>. The <italic>IFN-&#x003b3; </italic>+874A allele was overrepresented in SARS patients (83.1%) when compared with the controls (66.3%) (<italic>P </italic>&#x0003c; 0.001). It was also significantly associated with susceptibility to SARS in a dose-dependent manner (<italic>P </italic>&#x0003c; 0.001), i.e. individuals with <italic>IFN-&#x003b3; </italic>+874 AA and AT genotype had an odds ratio (OR) of 5.19 (95% CI, 2.78-9.68) and 2.57 (95% CI, 1.35-4.88) in developing SARS respectively. However, no significant correlation was observed in SNPs of <italic>IL-10 </italic>and <italic>TNF-&#x003b1;</italic>. All SNPs were in Hardy-Weinberg equilibrium (HWE) (<italic>P </italic>&#x0003e; 0.05) in SARS patients and controls by chi square test, except <italic>IL-10</italic>-592A/C.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Allele frequencies and genotype frequencies in SARS patients and controls*</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">SNP</td><td align="center">SARS (n = 476)</td><td align="center">Control (n = 449)</td><td align="center">OR (95% CI)</td><td align="center"><italic>P</italic></td></tr><tr><td></td><td align="center" colspan="2">Number (%)</td><td></td><td></td></tr></thead><tbody><tr><td align="center"><bold>Genotype</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>IFN-&#x003b3; </italic>+874</td><td></td><td></td><td></td><td align="center">&#x0003c;0.001</td></tr><tr><td align="center">A/A</td><td align="center">332 (69.8)</td><td align="center">203 (45.2)</td><td align="center">5.19 (2.78 &#x02013; 9.68)</td><td></td></tr><tr><td align="center">A/T</td><td align="center">127 (26.7)</td><td align="center">189 (42.1)</td><td align="center">2.57 (1.35 &#x02013; 4.88)</td><td></td></tr><tr><td align="center">T/T</td><td align="center">17 (3.6)</td><td align="center">57 (12.7)</td><td align="center">Reference</td><td></td></tr><tr><td align="center"><italic>IL-10 </italic>-1082</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A/A</td><td align="center">439 (92.2)</td><td align="center">411 (91.5)</td><td align="center">..</td><td></td></tr><tr><td align="center">A/G</td><td align="center">35 (7.4)</td><td align="center">38 (8.5)</td><td align="center">..</td><td></td></tr><tr><td align="center">G/G</td><td align="center">2 (0.4)</td><td align="center">0 (0)</td><td align="center">..</td><td></td></tr><tr><td align="center"><italic>IL-10 </italic>-592</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A/A</td><td align="center">244 (51.3)</td><td align="center">209 (46.6)</td><td align="center">..</td><td></td></tr><tr><td align="center">A/C</td><td align="center">188 (39.5)</td><td align="center">214 (47.7)</td><td align="center">..</td><td></td></tr><tr><td align="center">C/C</td><td align="center">44 (9.2)</td><td align="center">26 (5.8)</td><td align="center">..</td><td></td></tr><tr><td align="center"><italic>TNF-a </italic>-308</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">GG</td><td align="center">403 (84.7)</td><td align="center">377 (83.9)</td><td align="center">..</td><td></td></tr><tr><td align="center">GA</td><td align="center">70 (14.7)</td><td align="center">70 (15.6)</td><td align="center">..</td><td></td></tr><tr><td align="center">AA</td><td align="center">3 (0.6)</td><td align="center">2 (0.5)</td><td align="center">..</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="center"><bold>Allele</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>IFN-&#x003b3; </italic>+874</td><td></td><td></td><td></td><td align="center">&#x0003c;0.001</td></tr><tr><td align="center">A</td><td align="center">791 (83.1)</td><td align="center">595 (66.3)</td><td align="center">2.23 (1.75 &#x02013; 2.83)</td><td></td></tr><tr><td align="center">T</td><td align="center">161 (16.9)</td><td align="center">303 (33.7)</td><td></td><td></td></tr><tr><td align="center"><italic>IL-10 </italic>-1082</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A</td><td align="center">913 (95.9)</td><td align="center">860 (95.8)</td><td align="center">..</td><td></td></tr><tr><td align="center">G</td><td align="center">39 (4.1)</td><td align="center">38 (4.2)</td><td align="center">..</td><td></td></tr><tr><td align="center"><italic>IL-10 </italic>-592</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A</td><td align="center">676 (71.0)</td><td align="center">632 (70.4)</td><td align="center">..</td><td></td></tr><tr><td align="center">C</td><td align="center">276 (29.0)</td><td align="center">266 (29.6)</td><td align="center">..</td><td></td></tr><tr><td align="center"><italic>TNF-a </italic>-308</td><td></td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">G</td><td align="center">876 (92.0)</td><td align="center">824 (91.8)</td><td align="center">..</td><td></td></tr><tr><td align="center">A</td><td align="center">76 (8.0)</td><td align="center">74 (8.2)</td><td align="center">..</td><td></td></tr></tbody></table><table-wrap-foot><p>NS = not significant.</p><p>*<italic>P</italic>-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age.</p></table-wrap-foot></table-wrap><p><italic>IFN-&#x003b3; </italic>+874A allele has been previously reported to be associated with infectious diseases such as tuberculosis, hepatitis B virus infection, and parvovirus infection [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>], revealing its potential role of function in host defense against microbial infections. The mechanism by which the <italic>IFN-&#x003b3; </italic>+874A/T allele influences the susceptibility to SARS may depend on its role in the regulation of IFN-&#x003b3; production. The T allele of <italic>IFN-&#x003b3; </italic>+874A/T provides a binding site for the transcription factor nuclear factor-&#x003ba;B (NF-&#x003ba;B), which is able to regulate <italic>IFN-&#x003b3; </italic>expression [<xref ref-type="bibr" rid="B23">23</xref>]. It is possible that low IFN-&#x003b3; production may impair their anti-viral response against SARS-CoV, rendering these individuals more susceptible to this virus infection. Our observation that <italic>IFN-&#x003b3; </italic>+874A allele was significantly associated with SARS-CoV infection suggests a genetic risk factor for SARS. The role of IFN-&#x003b3; in antiviral response against SARS-CoV has also been supported by recent studies showing that IFN-&#x003b3; can inhibit the replication of SARS-CoV in combination with IFN-&#x003b2; <italic>in vitro </italic>[<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>].</p><p><italic>IL-10 </italic>and <italic>TNF-&#x003b1; </italic>SNPs were also included in this study. They were chosen due to their potential regulation on protein expression level [<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B28">28</xref>]. However, our present data did not show any significant association of these SNPs with SARS (Table <xref ref-type="table" rid="T2">2</xref>). Nevertheless, we cannot exclude the role of <italic>IL-10 </italic>and <italic>TNF-&#x003b1; </italic>as the susceptibility genes for SARS, because other SNPs in these 2 genes may also be involved in gene expression regulation. Further association studies on other SNPs, which could alter the gene expression level are required to ascertain the relationship of <italic>IL-10 </italic>and <italic>TNF-&#x003b1; </italic>in SARS.</p><p>We have also compared the genotype and allele frequencies of all the polymorphisms between the death group and survival group of the SARS patients (Table <xref ref-type="table" rid="T3">3</xref>). However, no significant association was established.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Genotype frequencies among survival and death SARS cases</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">SNP</td><td align="center">Death (n = 57)</td><td align="center">Survival (n = 415)</td><td align="center"><italic>P</italic></td></tr><tr><td></td><td align="center" colspan="2">Number (%)</td><td></td></tr></thead><tbody><tr><td align="center"><bold>Genotype</bold></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>IFN-&#x003b3; </italic>+874</td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A/A</td><td align="center">41 (71.9)</td><td align="center">289 (69.6)</td><td></td></tr><tr><td align="center">A/T</td><td align="center">13 (22.8)</td><td align="center">112 (27.0)</td><td></td></tr><tr><td align="center">T/T</td><td align="center">3 (5.3)</td><td align="center">14 (3.4)</td><td></td></tr><tr><td align="center"><italic>IL-10</italic>-1082</td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A/A</td><td align="center">52 (91.2)</td><td align="center">383 (92.3)</td><td></td></tr><tr><td align="center">A/G</td><td align="center">4 (7.0)</td><td align="center">31 (7.5)</td><td></td></tr><tr><td align="center">G/G</td><td align="center">1 (1.8)</td><td align="center">1 (0.2)</td><td></td></tr><tr><td align="center"><italic>IL-10</italic>-592</td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">A/A</td><td align="center">28 (49.1)</td><td align="center">214 (51.6)</td><td></td></tr><tr><td align="center">A/C</td><td align="center">21 (36.8)</td><td align="center">165 (39.8)</td><td></td></tr><tr><td align="center">C/C</td><td align="center">8 (14.0)</td><td align="center">36 (8.7)</td><td></td></tr><tr><td align="center"><italic>TNF-a</italic>-308</td><td></td><td></td><td align="center">NS</td></tr><tr><td align="center">GG</td><td align="center">46 (80.7)</td><td align="center">353 (85.1)</td><td></td></tr><tr><td align="center">GA</td><td align="center">11 (19.3)</td><td align="center">59 (14.2)</td><td></td></tr><tr><td align="center">AA</td><td align="center">0 (0)</td><td align="center">3 (0.7)</td><td></td></tr></tbody></table><table-wrap-foot><p>NS = not significant.</p></table-wrap-foot></table-wrap></sec><sec><title>Conclusion</title><p>We demonstrated that <italic>IFN-&#x003b3; </italic>+874A allele was significantly associated with SARS susceptibility in a dose dependent manner. Due to its role in regulating IFN-&#x003b3; expression [<xref ref-type="bibr" rid="B15">15</xref>], this allele may be involved in the pathogenesis of SARS by altering the IFN-&#x003b3; production.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>WPC and WKEI: Genotyping, data analyses, drafting the manuscript</p><p>GHWT: Genotyping</p><p>MWN and WHSW: Data analyses, drafting the manuscript</p><p>HKWL, RWHY, EYC, KLA, EYTC: Sample collection, revising for medical content</p><p>WL and JSMP: Sample collection, providing virological data</p><p>YLL: Study design, conception and co-ordination, drafting the manuscript</p><p>All authors contributed to writing of the final manuscript</p><p>All authors read and approved the final manuscript</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/6/82/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work is supported by the Outstanding Researcher Awards (YLL &#x00026; JSMP), Postgraduate Studentships (WPC, GHWT, MWN) from the University of Hong Kong, the Research Fund for the Control of Infectious Diseases (03040302) from the Health, Welfare and Food Bureau of theHong Kong SAR Government and Edward Sai Kim Hotung Paediatric Education and Research Fund.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Lai</surname><given-names>ST</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yam</surname><given-names>LY</given-names></name><name><surname>Lim</surname><given-names>W</given-names></name><name><surname>Nicholls</surname><given-names>J</given-names></name><name><surname>Yee</surname><given-names>WK</given-names></name><name><surname>Yan</surname><given-names>WW</given-names></name><name><surname>Cheung</surname><given-names>MT</given-names></name><name><surname>Cheng</surname><given-names>VC</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Tsang</surname><given-names>DN</given-names></name><name><surname>Yung</surname><given-names>RW</given-names></name><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><collab>SARS study group</collab></person-group><article-title>Coronavirus as a possible cause of severe acute respiratory syndrome</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>1319</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">12711465</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13077-2</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group><article-title>Severe acute respiratory syndrome</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>S88</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15577937</pub-id><pub-id pub-id-type="doi">10.1038/nm1143</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>YL</given-names></name><name><surname>Peiris</surname><given-names>JM</given-names></name></person-group><article-title>Pathogenesis of severe acute respiratory syndrome</article-title><source>Curr Opin Immunol</source><year>2005</year><volume>17</volume><fpage>404</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15950449</pub-id><pub-id pub-id-type="doi">10.1016/j.coi.2005.05.009</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>CM</given-names></name><name><surname>Matukas</surname><given-names>LM</given-names></name><name><surname>Tomlinson</surname><given-names>GA</given-names></name><name><surname>Rachlis</surname><given-names>AR</given-names></name><name><surname>Rose</surname><given-names>DB</given-names></name><name><surname>Dwosh</surname><given-names>HA</given-names></name><name><surname>Walmsley</surname><given-names>SL</given-names></name><name><surname>Mazzulli</surname><given-names>T</given-names></name><name><surname>Avendano</surname><given-names>M</given-names></name><name><surname>Derkach</surname><given-names>P</given-names></name><name><surname>Ephtimios</surname><given-names>IE</given-names></name><name><surname>Kitai</surname><given-names>I</given-names></name><name><surname>Mederski</surname><given-names>BD</given-names></name><name><surname>Shadowitz</surname><given-names>SB</given-names></name><name><surname>Gold</surname><given-names>WL</given-names></name><name><surname>Hawryluck</surname><given-names>LA</given-names></name><name><surname>Rea</surname><given-names>E</given-names></name><name><surname>Chenkin</surname><given-names>JS</given-names></name><name><surname>Cescon</surname><given-names>DW</given-names></name><name><surname>Poutanen</surname><given-names>SM</given-names></name><name><surname>Detsky</surname><given-names>AS</given-names></name></person-group><article-title>Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>2801</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12734147</pub-id><pub-id pub-id-type="doi">10.1001/jama.289.21.JOC30885</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JW</given-names></name><name><surname>Ng</surname><given-names>CK</given-names></name><name><surname>Chan</surname><given-names>YH</given-names></name><name><surname>Mok</surname><given-names>TY</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chu</surname><given-names>SY</given-names></name><name><surname>Law</surname><given-names>WL</given-names></name><name><surname>Lee</surname><given-names>MP</given-names></name><name><surname>Li</surname><given-names>PC</given-names></name></person-group><article-title>Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)</article-title><source>Thorax</source><year>2003</year><volume>58</volume><fpage>686</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12885985</pub-id><pub-id pub-id-type="doi">10.1136/thorax.58.8.686</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Hedley</surname><given-names>AJ</given-names></name><name><surname>Ho</surname><given-names>LM</given-names></name><name><surname>Chau</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>IO</given-names></name><name><surname>Thach</surname><given-names>TQ</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Tsang</surname><given-names>T</given-names></name><name><surname>Leung</surname><given-names>PY</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Tsui</surname><given-names>E</given-names></name><name><surname>Lo</surname><given-names>SV</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name></person-group><article-title>The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>662</fpage><lpage>73</lpage><comment>Summary for patients in: Ann Intern Med 2004;141: I63.</comment><pub-id pub-id-type="pmid">15520422</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>WK</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Law</surname><given-names>HK</given-names></name><name><surname>Tso</surname><given-names>GH</given-names></name><name><surname>Kong</surname><given-names>EK</given-names></name><name><surname>Wong</surname><given-names>WH</given-names></name><name><surname>To</surname><given-names>YF</given-names></name><name><surname>Yung</surname><given-names>RW</given-names></name><name><surname>Chow</surname><given-names>EY</given-names></name><name><surname>Au</surname><given-names>KL</given-names></name><name><surname>Chan</surname><given-names>EY</given-names></name><name><surname>Lim</surname><given-names>W</given-names></name><name><surname>Jensenius</surname><given-names>JC</given-names></name><name><surname>Turner</surname><given-names>MW</given-names></name><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Lau</surname><given-names>YL</given-names></name></person-group><article-title>Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>1697</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">15838797</pub-id><pub-id pub-id-type="doi">10.1086/429631</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Zhi</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>F</given-names></name></person-group><article-title>Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection</article-title><source>J Infect Dis</source><year>2005</year><volume>192</volume><fpage>1355</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16170752</pub-id><pub-id pub-id-type="doi">10.1086/491479</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>VS</given-names></name><name><surname>Chan</surname><given-names>KY</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Cheung</surname><given-names>AN</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Mak</surname><given-names>W</given-names></name><name><surname>Ngan</surname><given-names>HY</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Screaton</surname><given-names>G</given-names></name><name><surname>Tam</surname><given-names>PK</given-names></name><name><surname>Austyn</surname><given-names>JM</given-names></name><name><surname>Chan</surname><given-names>LC</given-names></name><name><surname>Yip</surname><given-names>SP</given-names></name><name><surname>Peiris</surname><given-names>M</given-names></name><name><surname>Khoo</surname><given-names>US</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name></person-group><article-title>Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16369534</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>CA</given-names></name><name><surname>Nguyen</surname><given-names>KB</given-names></name><name><surname>Pien</surname><given-names>GC</given-names></name><name><surname>Cousens</surname><given-names>LP</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name></person-group><article-title>Natural killer cells in antiviral defense: function and regulation by innate cytokines</article-title><source>Annu Rev Immunol</source><year>1999</year><volume>17</volume><fpage>189</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">10358757</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.17.1.189</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makhatadze</surname><given-names>NJ</given-names></name></person-group><article-title>Tumor necrosis factor locus: genetic organisation and biological implications</article-title><source>Hum Immunol</source><year>1998</year><volume>59</volume><fpage>571</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9757913</pub-id><pub-id pub-id-type="doi">10.1016/S0198-8859(98)00056-1</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulligan</surname><given-names>MS</given-names></name><name><surname>Varani</surname><given-names>J</given-names></name><name><surname>Dame</surname><given-names>MK</given-names></name><name><surname>Lane</surname><given-names>CL</given-names></name><name><surname>Smith</surname><given-names>CW</given-names></name><name><surname>Anderson</surname><given-names>DC</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><article-title>Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats</article-title><source>J Clin Invest</source><year>1991</year><volume>88</volume><fpage>1396</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">1717513</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulligan</surname><given-names>MS</given-names></name><name><surname>Vaporciyan</surname><given-names>AA</given-names></name><name><surname>Miyasaka</surname><given-names>M</given-names></name><name><surname>Tamatani</surname><given-names>T</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><article-title>Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1</article-title><source>Am J Pathol</source><year>1993</year><volume>142</volume><fpage>1739</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">7685152</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiorentino</surname><given-names>DF</given-names></name><name><surname>Bond</surname><given-names>MW</given-names></name><name><surname>Mosmann</surname><given-names>TR</given-names></name></person-group><article-title>Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production</article-title><source>J Exp Med</source><year>1989</year><volume>170</volume><fpage>2081</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">2531194</pub-id><pub-id pub-id-type="doi">10.1084/jem.170.6.2081</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KW</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><article-title>Interleukin-10 and the interleukin-10 receptor</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>683</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">11244051</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.683</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>G</given-names></name></person-group><article-title>Effect of interleukin-10 (IL-10) on experimental LPS-induced acute lung injury</article-title><source>J Infect Chemother</source><year>2000</year><volume>6</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11810532</pub-id><pub-id pub-id-type="doi">10.1007/s101560050050</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panuska</surname><given-names>JR</given-names></name><name><surname>Merolla</surname><given-names>R</given-names></name><name><surname>Rebert</surname><given-names>NA</given-names></name><name><surname>Hoffmann</surname><given-names>SP</given-names></name><name><surname>Tsivitse</surname><given-names>P</given-names></name><name><surname>Cirino</surname><given-names>NM</given-names></name><name><surname>Silverman</surname><given-names>RH</given-names></name><name><surname>Rankin</surname><given-names>JA</given-names></name></person-group><article-title>Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity</article-title><source>J Clin Invest</source><year>1995</year><volume>95</volume><fpage>2445</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7593633</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Standiford</surname><given-names>TJ</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Lukacs</surname><given-names>Nw</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name></person-group><article-title>Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>2222</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7636269</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalechman</surname><given-names>Y</given-names></name><name><surname>Gafter</surname><given-names>U</given-names></name><name><surname>Gal</surname><given-names>R</given-names></name><name><surname>Rushkin</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Albeck</surname><given-names>M</given-names></name><name><surname>Sredni</surname><given-names>B</given-names></name></person-group><article-title>Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>384</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">12077268</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tso</surname><given-names>HW</given-names></name><name><surname>Ip</surname><given-names>WK</given-names></name><name><surname>Chong</surname><given-names>WP</given-names></name><name><surname>Tam</surname><given-names>CM</given-names></name><name><surname>Chiang</surname><given-names>AKS</given-names></name><name><surname>Lau</surname><given-names>YL</given-names></name></person-group><article-title>Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese</article-title><source>Genes Immun</source><year>2005</year><volume>6</volume><fpage>358</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15815688</pub-id><pub-id pub-id-type="doi">10.1038/sj.gene.6364189</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Z</given-names></name><name><surname>Mor</surname><given-names>E</given-names></name><name><surname>Papo</surname><given-names>O</given-names></name><name><surname>Kfir</surname><given-names>B</given-names></name><name><surname>Sulkes</surname><given-names>J</given-names></name><name><surname>Tambur</surname><given-names>AR</given-names></name><name><surname>Tur-Kaspa</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>T</given-names></name></person-group><article-title>Cytokine gene polymorphisms in patients infected with hepatitis B virus</article-title><source>Am J Gastroenterol</source><year>2003</year><volume>98</volume><fpage>144</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">12526950</pub-id><pub-id pub-id-type="doi">10.1111/j.1572-0241.2003.07169.x</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>JR</given-names></name><name><surname>McCoy</surname><given-names>M</given-names></name><name><surname>Burke</surname><given-names>B</given-names></name><name><surname>Mattey</surname><given-names>DL</given-names></name><name><surname>Pravica</surname><given-names>V</given-names></name><name><surname>Hutchinson</surname><given-names>IV</given-names></name></person-group><article-title>Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection</article-title><source>J Clin Pathol</source><year>2003</year><volume>56</volume><fpage>725</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14514772</pub-id><pub-id pub-id-type="doi">10.1136/jcp.56.10.725</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pravica</surname><given-names>V</given-names></name><name><surname>Perrey</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Hutchinson</surname><given-names>IV</given-names></name></person-group><article-title>A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production</article-title><source>Hum Immunol</source><year>2000</year><volume>61</volume><fpage>863</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11053629</pub-id><pub-id pub-id-type="doi">10.1016/S0198-8859(00)00167-1</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scagnolari</surname><given-names>C</given-names></name><name><surname>Vicenzi</surname><given-names>E</given-names></name><name><surname>Bellomi</surname><given-names>F</given-names></name><name><surname>Stillitano</surname><given-names>MG</given-names></name><name><surname>Pinna</surname><given-names>D</given-names></name><name><surname>Poli</surname><given-names>G</given-names></name><name><surname>Clementi</surname><given-names>M</given-names></name><name><surname>Dianzani</surname><given-names>F</given-names></name><name><surname>Antonelli</surname><given-names>G</given-names></name></person-group><article-title>Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons</article-title><source>Antivir Ther</source><year>2004</year><volume>9</volume><fpage>1003</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15651759</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sainz</surname><given-names>B</given-names><suffix>Jr</suffix></name><name><surname>Mossel</surname><given-names>EC</given-names></name><name><surname>Peters</surname><given-names>CJ</given-names></name><name><surname>Garry</surname><given-names>RF</given-names></name></person-group><article-title>Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)</article-title><source>Virology</source><year>2004</year><volume>329</volume><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15476870</pub-id><pub-id pub-id-type="doi">10.1016/j.virol.2004.08.011</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>DM</given-names></name><name><surname>Williams</surname><given-names>DM</given-names></name><name><surname>Sankaran</surname><given-names>D</given-names></name><name><surname>Lazarus</surname><given-names>M</given-names></name><name><surname>Sinnott</surname><given-names>PJ</given-names></name><name><surname>Hutchinson</surname><given-names>IV</given-names></name></person-group><article-title>An investigation of polymorphism in the interleukin-10 gene promoter</article-title><source>Eur J Immunogenet</source><year>1997</year><volume>24</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9043871</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>E</given-names></name><name><surname>Kay</surname><given-names>R</given-names></name><name><surname>Sillibourne</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Hutchinson</surname><given-names>I</given-names></name><name><surname>Woo</surname><given-names>P</given-names></name></person-group><article-title>Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis</article-title><source>Arthritis Rheum</source><year>1999</year><volume>42</volume><fpage>1101</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10366102</pub-id><pub-id pub-id-type="doi">10.1002/1529-0131(199906)42:6&#x0003c;1101::AID-ANR6&#x0003e;3.0.CO;2-Y</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>AG</given-names></name><name><surname>Symons</surname><given-names>JA</given-names></name><name><surname>McDowell</surname><given-names>TL</given-names></name><name><surname>McDevitt</surname><given-names>HO</given-names></name><name><surname>Duff</surname><given-names>GW</given-names></name></person-group><article-title>Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><fpage>3195</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9096369</pub-id><pub-id pub-id-type="doi">10.1073/pnas.94.7.3195</pub-id></citation></ref></ref-list></back></article> 